Bafrekalant

Overview

Bafrekalant is a diazabicyclic substituted imidazo[l,2-a]pyrimidine-derivative. Bafrekalant has the potential for the research of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring (extracted from patent WO2018228907A1).

Application

Products | Products > Signaling Pathways > Others | Products > Research Areas > Others | Products > Signaling Pathways > Drug Derivative

Product Information

• Catalog No.: HY-145554
• CAS No.: 2256770-44-0
• Molecular Formula: C29H31ClN6O2
• Molecular Weight: 531.05
• Purity: 99.80%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.08 mg/mL (3.92 mM); Clear solution
• Availability: In-stock

Source

Original product source